May 5, 2017 / 12:56 AM / 4 months ago

BRIEF-Biotech Capital says unit Bioimpact enters into license agreement with RLS Global

May 5 (Reuters) - Biotech Capital Ltd :

* Bioimpact enters into license agreement with RLS Global

* Agreement grants Co rights to distribute wound care product, within Australia, New Zealand and select countries across Asia Pacific region Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below